Syneos Health stockholders approve agreement with investor consortium

Syneos Health stockholders approved an agreement to take the Company private through an acquisition by a consortium of private investment firm affiliates comprised of Elliott Investment Management L.P., Patient Square Capital, and Veritas Capital at a special meeting of stockholders held earlier today. As previously announced, under the terms of the agreement, Syneos Health stockholders will receive $43.00 in cash for each share of Syneos Health common stock owned at the closing of the transaction, if completed. Completion of the transaction is expected in the second half of 2023, subject to the satisfaction of customary closing conditions, including regulatory approvals. The final voting results of the Syneos Health special meeting will be reported in a Form 8-K to be filed by Syneos Health with the U.S. Securities and Exchange Commission.